JP2017083998A - Prescription check device and prescription check method - Google Patents

Abstract

PROBLEM TO BE SOLVED: To surely check a name of disease, even when a complicated indication name containing plural coexistence disease names and qualifiers is associated to one medical product.SOLUTION: A prescription check device comprises: a master database for storing for each medical product, a first adaptive disease name and a second adaptive disease name to the medical product, or a first qualifier to the first adaptive disease name; and a control part for determining whether or not to check other adaptive disease name which is different from the adaptive disease name which is same to the first adaptive disease name, and is contained in indication information, when the adaptive disease name contained in indication information of a medical product which is a check object is same to the first adaptive disease name, or whether or not to check a qualifier contained in the indication information, and if the check is required, detecting whether or not other adaptive disease name contained in the indication information or the qualifier contained in the indication information is same to the second adaptive disease name or the first qualifier, and if the other adaptive disease name or the qualifier is not same to the second adaptive disease name or first qualifier, executing a display which indicates that the second adaptive disease name or the first qualifier is not contained in the indication information.SELECTED DRAWING: Figure 1

Description

  The present invention relates to a prescription check apparatus and a prescription check method for checking a disease name corresponding to a medicine prescribed by a doctor.

  “In-hospital receipt check” is an insurance claim work performed by medical institutions. This is an operation to check the contents of the medical fee remuneration statement (hereinafter referred to as “Receive”) that has been prepared, and the assessment organization's assessment reduction (drugs judged to be incomplete) due to incomplete receipt. It is also important to prevent medical practice points from being paid to medical institutions.

  In the “in-hospital receipt check”, it is the “disease name leak check” that needs to be checked with particular care. This is a check to see if the name of the disease applicable to the treatment performed by the doctor on the patient is written in the name column of the wound. The score for treatment that does not have an applicable disease name is subject to assessment reduction by the reviewing agency.

  The medical fee review and payment institution has conducted a “match check” that electronically compares medical and dispensing receipts since the March 2012 review, so that out-of-hospital prescribing medical institutions are strictly screening for disease name leaks. Has come to be done.

  For medicines prescribed to patients, if the indication described in the indication effect of the package insert is not described in the name column of the wound, the score of the drug is deducted.

  A computer for medical office calculation (hereinafter referred to as “Resecon”) will check whether the indication for the prescribed drug is listed in the receipt so that such assessment can be confirmed before submitting the receipt. A function is installed (see, for example, Patent Document 1).

  Information on indications for drugs is compiled as a “drug name master database for drug indications”, and the contents of the data are regularly updated in accordance with the price listing of new drugs or revisions to package inserts.

This drug indication disease name master database holds the code information (variable number) of indications for one drug, but the package insert has a relationship between multiple comorbid disease names and modifiers as shown below. Some have complicated indications.
(1) Requires multiple comorbidities (combination tablets containing different ingredients).
"Disease name B associated with disease name A", "Disease name B based on disease name A"
(2) Indications require modifiers such as site and pathology.
"Disease name A (mild or moderate)"
(3) If a specific modifier is added, it is not regarded as an indication.
"Disease name A (excluding delayed onset)"

JP-A-6-076005

  In the conventional receptacle, master data and check processing logic for complicated indications as described in the above (1) to (3) are very complicated, and it is difficult to realize the “disease name check” function. Therefore, in the case of the cases (1) to (3) above, a check error cannot be detected by the system, and it is necessary for the medical staff to visually check the contents of the receipt, resulting in leakage of the disease name. There was a fear. In addition, the in-hospital receipt check work time is increased and the work efficiency is lowered.

  An object of the present invention is to provide a prescription check apparatus and a prescription check method capable of surely executing a disease name check even if a complex medicine name including a plurality of comorbid disease names and modifiers is associated with one drug. It is.

  The prescription check device according to one aspect of the present invention includes, for each drug, a master database that stores a first indication name and a second indication name for the drug, or a first modifier for the first indication name; If the indication of the indication included in the indication information of the drug to be checked, or the modifier for the indication of the indication and the indication of the indication, and the indication of the indication included in the indication information matches the name of the first indication, the first Indication information is determined by determining whether it is necessary to check other indications that are different from the indications that match the indications and that are included in the indications, or the modifiers that are included in the indications. If it is necessary to check the name of other indications included in the information or the modifiers included in the indication information, the names of other indications included in the indication information or the modifications included in the indication information Detects whether or not it matches the second indication name or the first modifier, and if it does not match, the second indication name or the first modifier indicates the indication information And a control unit for executing a display indicating that it is not included.

  The prescription check method according to one aspect of the present invention uses, for each drug, a master database that stores a first indication name and a second indication name for the drug, or a first modifier for the first indication name. A prescription check method to be performed, the step of obtaining an indication name of an indication included in the indication information of a drug to be checked, or an indication of an indication of an indication and an indication of an indication, and an indication of the indication of the indication included in the indication of the indication If there is a match with the disease name, is it necessary to check other indications that are different from the indication that matches the first indication and that is included in the indication, or a modifier that is included in the indication? If it is necessary to check the name of the other indications included in the indication information, or check the modifiers included in the indication information, the indication information In the case where it does not coincide with the step of detecting whether or not the other indications included or the modifier included in the indication information matches the second indication or the first modifier. And executing a display indicating that the second indication name or the first modifier is not included in the indication information.

  According to the present invention, a disease name can be surely checked even if a complex medicine name including a plurality of comorbid disease names and modifiers is associated with one drug.

The block diagram which shows the structure of the prescription check apparatus which concerns on embodiment of this invention Figure showing an example of the creation database Figure showing an example of the pharmaceutical product master database The figure which shows an example of an indication disease name master database The figure which shows an example of check master database, such as a comorbidity name Diagram for explaining the outline of the receipt check in the prescription check device The figure for explaining the receipt check result when the indication disease name is not registered in the receipt disease name The figure for explaining the receipt check result when the disease name which is indicated alone is registered in the receipt disease name The figure for explaining the receipt check result when only one of the comorbidity names is registered in the receipt disease name The figure for demonstrating the receipt check result when the disease name which has the combination of a "modifier + disease name" in the name of a coexisting disease is not registered in the name of a disease disease The figure for explaining the receipt check result when the modifier except “to” is registered in the name of the receipt disease Flow chart showing the receipt check processing procedure of the prescription check device The flowchart which shows the receipt description check processing procedure, such as a coexisting disease name in FIG. The flowchart which shows the comparison processing procedure of the comorbid disease name code and the receipt disease name in FIG. FIG. 14 is a flowchart showing the procedure of a check process for checking whether or not the modifier of the check name database [x] of the coexisting disease name is added to the current disease name code [i] to be compared in FIG. The flowchart which shows the procedure of the check process whether the comorbid disease name of the complication disease name check master database [x]-[x + y] in FIG. 14 is registered in the same receipt disease name. The flowchart which shows the procedure of the check process whether the single code of the check master database of the remaining comorbid disease name etc. registration in FIG. 16 is registered in the same receipt disease name

  Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings.

  FIG. 1 is a block diagram showing a configuration of a prescription check device 100 according to an embodiment of the present invention. As shown in FIG. 1, the prescription check apparatus mainly includes an input IF unit 110, a display unit 120, a control unit 130, and a database 140.

  The input IF unit 110 is, for example, a keyboard, a mouse, and the like, and various information is input by an operator such as a medical staff.

  The display unit 120 is, for example, a liquid crystal display, an organic EL (Electro Luminescence) display, and the like, and displays characters, figures, images, and the like under the control of the control unit 130. The display unit 120 displays a screen for inputting a prescription drug code (prescription input screen), a screen for inputting a diagnosed disease name code (disease name input screen), and a receipt check result. The display unit 120 may be a touch panel display in which the input IF unit 110 and the display unit 120 are integrated.

  The control unit 130 controls the entire prescription check apparatus 100, receives an operator instruction input from the input IF unit 110, searches the database 140 to perform a receipt check, and causes the display unit 120 to display a receipt check result.

  The database 140 includes a creation database 142, a medicine master database 144, an indication disease name master database 146, and a complication disease name check master database 148.

  FIG. 2 is a diagram illustrating an example of the creation database 142. The creation database 142 is a medical database that holds information on a pharmaceutical code, a disease name code, and a modifier code input to the prescription check apparatus 100. In FIG. 2, the code name is a code character string that is designated when the code is input to the prescription check device 100. The FN is information for identifying a code type, that is, a drug code, a disease name code, and a modifier code. Here, FN21 = medicine, FN1 = disease name, and FN0 = modifier. The name is a name indicating a medicine name, a disease name, and a modifier displayed on the display unit 120. The master code is a maintenance code for the manufacturer. The receipt computer processing system code is master information that is publicly maintained on the examination and payment institution side, the medicine is represented by a 9-digit numerical value starting with the first 6, and the disease name is represented by a 7-digit numerical value. The modifier is represented by a 4-digit number.

  FIG. 3 is a diagram illustrating an example of the pharmaceutical master database 144. The drug master database 144 is a master database that stores all drug code information that is master-managed by the prescription check apparatus 100. In FIG. 3, the master code is a pharmaceutical master code and a link key with the master code of the creation database 142. The attached document ID is a numerical value uniquely assigned to each attached document.

  FIG. 4 is a diagram illustrating an example of the indication disease name master database 146. The indication disease name master database 146 is an indication of the indications described in the package insert for the medicines contained in the medicine master database 144 by the code for the receipt computer system. In the package insert, the disease name that corresponds to “requires multiple comorbidity names”, “requires specified qualifiers”, “excluding specified qualifiers” has a value of 1 or more in “check group ID for comorbidity names” Listed. In FIG. 4, the attached document ID is a numerical value uniquely assigned to each attached document, and is a link key with the attached document ID in the pharmaceutical master database 144. The indication code is an indication of the indication described in the package insert using the code for the receipt computer system. In addition, the check group ID of the comorbidity name etc. is set to a numerical value of 1 or more when there is a condition of other disease name or modifier (hereinafter referred to as “check condition of comorbidity name etc.”) for the disease name of the indication code. It is a thing. A disease name for which the condition for checking a comorbidity name is 1 or more is referred to as a check target disease name such as a comorbid disease name. However, when there is no condition for other disease names or modifiers (when the disease name alone is OK), the check group ID such as the name of a comorbid disease is 0. In addition, among the indications for the same drug, when the check conditions for the comorbid disease name and the like are the same, the same value is set in the check group ID for the comorbid disease name and the like.

  FIG. 5 is a diagram showing an example of the check master database 148 for comorbidity names and the like. The comorbid disease name check master database 148 is a database in which a breakdown of check conditions such as a comorbid disease name for a combination of a pharmaceutical product (attached document ID) and an indication code (a check group ID such as a comorbid disease name) is listed. However, the check group ID = 0 for comorbidity name etc. is not listed in this database because there is no information such as the name of the comorbidity. In FIG. 5, the attached document ID is a numerical value uniquely assigned to each attached document unit, and is a link key with the attached document ID of the adaptive disease name master database 146. Further, the check group ID for comorbidity name and the like is a link key with the check group ID for the comorbidity name and the like in the adaptive disease name master database 146. Further, the intra-group serial number is a serial number added from 1 in a group in which the attached document ID and the check group ID such as a coexisting disease name are the same. The disease name serial number is identification information for identifying a dependent source disease name for a check target disease name code such as a coexisting disease name. In the case of a disease name code, one or more unique serial numbers are set, and in the case of a modifier code, it is set as follows. In other words, 0 is set when subordinate to the name of the disease that has been received in the disease name input screen of the prescription check device 100, and the subordinate name of the comorbidity that is the subordinate is checked when subordinate to the name of the target disease to be checked. The same serial number as the target disease name is set. In the check process F, 1 is set when the check target disease name code such as the name of a comorbidity is “excluding”, and 0 is set otherwise. The disease name code to be checked such as the name of a comorbid disease is a disease name code (or a disease name code that needs to be registered) (or a disease name code that matches the disease name listed in the “adapted disease name master database 146”). The modifier code) is set by the code for the receipt computer processing system.

  Next, an outline of the receipt check in the prescription check apparatus 100 will be described with reference to FIG. First, the operator inputs a prescription drug code on the prescription input screen of the prescription check apparatus 100. The prescription check device 100 refers to the creation database 142 and obtains a master code corresponding to the input drug code from the creation database 142. In addition, the prescription check device 100 refers to the pharmaceutical master database 144 and acquires the attached document ID corresponding to the acquired master code from the pharmaceutical master database 144. Subsequently, the prescription check apparatus 100 refers to the indication disease name master database 146 and acquires a check group ID such as an indication code and a comorbidity name corresponding to the acquired attached document ID. Furthermore, the prescription check apparatus 100 refers to the comorbidity disease name check master database 148 and acquires a check target disease name code such as a comorbid disease name corresponding to the acquired attached document ID and the check group ID such as the comorbid disease name.

  On the other hand, the operator inputs the diagnosed disease name code on the disease name input screen of the prescription check apparatus 100. The prescription check device 100 refers to the creation database 142 and obtains a receipt computer processing system code corresponding to the input disease name code.

  The prescription check device 100 checks whether an indication code (a code for a receipt computer processing system) that matches a code for a receipt computer processing system (a receipt disease name) obtained by inputting a disease name code exists in the indication disease name master database. If there is a matching indication code, the prescription check apparatus 100 checks whether the name of the complication to be checked such as the comorbidity name check master database 148 corresponding to the indication code is registered in the receipt disease name.

  Next, a description will be given of a receipt check result in a case where an indication code having a check condition such as a coexisting disease name is included in the indication for disease name master database 146 of the medicine input to the prescription check apparatus 100.

  First, the case where the indication disease name is not registered in the receipt disease name will be described with reference to FIG. Here, the package insert of “Pharmaceutical A 10 mg” is as shown in FIG. 7 (a), and the effect is the disease name C based on the disease name A or disease name B, the disease name E associated with the disease name D, the disease name F, the disease name G Is targeted. However, it is only necessary that the name of the disease is registered as one of “disease name A and disease name C”, “disease name B and disease name C”, “disease name D and disease name E”, “disease name F”, and “disease name G”. .

  The operator inputs a drug code for specifying 10 mg of drug on the prescription input screen of the prescription check apparatus 100 (FIG. 7B), and inputs a disease name code for specifying the disease name H on the disease name input screen of the prescription check apparatus 100. (FIG. 7C). The prescription check device 100 searches the indication disease name master database 146 (FIG. 7 (d)) and the coexisting disease name check master database 148 (FIG. 7 (e)) based on the inputted drug code. It turns out that it is not an indication disease name of “pharmaceutical 10 mg”, and an error is output as a receipt check result (FIG. 7 (f)). FIG. 7 (f) is an example of the receipt check result, and the indication of disease name (indication) listed in the indication disease name master database 146 is displayed as the indication of indication disease. In addition, a mark “&” that identifies the disease name that is not indicated only by the disease name is added. That is, even if only a disease name to which the “&” mark is added is added to the disease name input screen, the receipt check result is not OK.

  Next, a case where a disease name that is indicated alone is registered in the name of a receipt disease will be described with reference to FIG. Here again, the package insert of “Pharmaceutical A 10 mg” is as shown in FIG. 8 (a), and the effect is the disease name C based on disease name A or disease name B, disease name E associated with disease name D, disease name F, disease name G Is targeted. However, it is only necessary that the name of the disease is registered as one of “disease name A and disease name C”, “disease name B and disease name C”, “disease name D and disease name E”, “disease name F”, and “disease name G”. .

  The operator inputs a drug code for specifying 10 mg of drug in the prescription input screen of the prescription check apparatus 100 (FIG. 8B), and inputs a disease name code for specifying the disease name F in the disease name input screen of the prescription check apparatus 100. (FIG. 8C). When the prescription check device 100 searches the indication disease name master database 146 (FIG. 8D) based on the inputted drug code, the check group ID of the disease name F of the comorbid disease name etc. is 0. The database 148 (FIG. 8 (e)) is not searched. The prescription check apparatus 100 turns out that the disease name F is an indication disease name of “pharmaceutical 10 mg”, and outputs OK as a result of the receipt check.

  Next, the case where only one of the check target disease names such as the names of comorbid diseases is registered in the receipt disease name will be described with reference to FIG. Here again, the package insert of “Pharmaceutical A 10 mg” is as shown in FIG. 9 (a), and the effect is the disease name C based on disease name A or disease name B, disease name E associated with disease name D, disease name F, disease name G Is targeted. However, it is only necessary that the name of the disease is registered as one of “disease name A and disease name C”, “disease name B and disease name C”, “disease name D and disease name E”, “disease name F”, and “disease name G”. .

  The operator inputs a drug code for specifying 10 mg of drug A on the prescription input screen of the prescription check device 100 (FIG. 9B), and specifies a disease name C and a disease name H on the disease name input screen of the prescription check device 100, respectively. A disease name code is input (FIG. 9C). When the prescription check device 100 searches the indication disease name master database 146 (FIG. 9D) based on the inputted medicine code, the check group ID of the comorbidity name etc. of the disease name C is 2 (there is a check condition for the comorbidity name etc.) Therefore, a check master database 148 (FIG. 9 (e)) such as the name of a comorbid disease is searched. The prescription check device 100 determines from the comorbid disease name check master database 148 that the disease names to be checked such as the comorbid disease name are disease name A and disease name B, and these disease names are not registered in the receptor disease name, and as a result of the receipt check. An error is output (FIG. 9 (f)). FIG. 9 (f) is an example of the receipt check result. In the receipt disease name column, indications for drugs (disease names that have already been registered as receipt disease names) are displayed, and in the comorbidity name column, a complication disease name etc. check master is displayed. The name of the disease to be checked such as the names of comorbidities in the database (other disease names that require receipt disease name registration) are displayed. If any of the names of diseases to be checked such as the names of comorbid diseases displayed in the column of comorbidities is additionally registered in the name of the received disease, the receipt check becomes OK.

  Next, a case where a disease name having a combination of “modifier + disease name” as a disease name to be checked such as a coexisting disease name is not registered in the receipt disease name will be described with reference to FIG. Here, the package insert of “Pharmaceutical A 20 mg” is as shown in FIG. 10A, and the effect is targeted on the disease name C associated with the disease name A (mild or moderate). However, it is only necessary that the name of the received disease is registered as any one of “(mild + disease name A) and disease name C”, “(moderate + disease name A) and disease name C”, and “disease name B”.

  The operator inputs a medicine code for specifying 20 mg of medicine A on the prescription input screen of the prescription check apparatus 100 (FIG. 10B), and specifies a disease name C and a disease name H on the disease name input screen of the prescription check apparatus 100, respectively. A disease name code is input (FIG. 10C). When the prescription check apparatus 100 searches the indication disease name master database 146 (FIG. 10 (d)) based on the inputted drug code, the check group ID of the comorbidity name etc. of the disease name C is 2 (there is a check condition for the comorbidity name etc.) Therefore, a check master database 148 (FIG. 10 (e)) such as a co-morbid disease name is searched. The prescription check apparatus 100 determines that the check disease name such as a coexisting disease name is “mild + disease name A” or “moderate + disease name B” from the check master database 148 of a coexisting disease name, and these disease names are registered in the receipt disease name. Therefore, an error is output as a receipt check result (FIG. 10 (f)). FIG. 10F shows an example of the receipt check result. In the comorbid disease name column, a modifier and a disease name are displayed as a check target disease name of the comorbid disease name check master database. However, “+” is added to the end of the modifier for the immediately following modifier, and “+” is added to the beginning of the modifier for the modifier dependent on the immediately preceding disease. Also, as a rule, suffixes (Receive computer processing system code = 8000-8999) display a dependent disease name immediately before by adding “+” to the beginning of the modifier. In other cases, a dependent disease name is displayed immediately after adding “+” to the end of the modifier. If the combination of the modifier and the disease name displayed in the co-morbid disease name column is additionally registered in the receipt disease name, the receipt check is OK.

  Next, the case where the disease name “excluding” is registered in the name of the receipt disease will be described with reference to FIG. Here, the package insert of “Pharmaceutical C 10 mg” is as shown in FIG. 11 (a), and the efficacy and effects are as follows: disease name A (excluding mild and moderate), disease name B (excluding delayed onset), disease name Target C. It should be noted that the name of the disease that has been received may be registered as any of “disease name A”, “disease name B”, and “disease name C”. However, “mild + disease name A”, “moderate + disease name A”, and “late onset + disease name B” are not applicable and are considered errors.

  The operator inputs a drug code for specifying 10 mg of drug C on the prescription input screen of the prescription check apparatus 100 (FIG. 11B), and a disease name code for specifying the mild disease name A on the disease name input screen of the prescription check apparatus 100. It inputs (FIG.11 (c)). When the prescription check apparatus 100 searches the indication disease name master database 146 (FIG. 11 (d)) based on the inputted medicine code, the check group ID of the comorbidity name etc. of the disease name A is 1 (there is a check condition for the comorbidity name etc.) Therefore, a check master database 148 (FIG. 11 (e)) such as a co-morbid disease name is searched. The prescription check apparatus 100 determines that there is a modifier for exclusion from the complication disease name check master database 148, and outputs an error as a receipt check result because this modifier for exclusion is added to the name of the received disease. (FIG. 11 (f)). FIG. 11 (f) is an example of the receipt check result, but “modifier + disease name” which is an error target is displayed in the receipt disease name column. In the modifier column, a modifier to be excluded added to the name of the receptor disease is displayed. If the exclusion modifier is deleted (or replaced with another modifier), the receipt check becomes OK.

  Next, the receipt check processing procedure of the prescription check apparatus 100 will be described with reference to FIG. In step S01, the control unit 130 receives a medicine code by the operator. In step S02, the control unit 130 acquires an attached document ID from the pharmaceutical master database 144 using the master code corresponding to the pharmaceutical code as a link key.

  In step S03, the control unit 130 acquires the indication code from the indication disease name master database 146 using the attached document ID as a link key. In step S04, the names of all the received diseases of the patient to be checked are acquired.

  In step S05, the control unit 130 starts loop processing from the beginning to the end of data (EOD: end-of-data) for the acquired disease name data. If the process has not been completed up to EOD (NO), the process proceeds to step S06, and if the process has been completed up to EOD (YES), the process proceeds to step S13.

  In step S06, the control unit 130 starts loop acquisition for each indication code from the top to EOD for the indication codes in the indication disease name master database 146. If the acquisition has not been completed up to EOD (NO), the process proceeds to step S07. If the process has been completed up to EOD (YES), the process returns to step S05.

  In step S07, the control unit 130 determines whether or not the single code of the receptor disease name [i] matches the code for the receipt computer processing system of the adaptive disease name master database [m]. If they match (YES), the process proceeds to step S08. If they do not match (NO), the process returns to step S06.

  In step S08, the control unit 130 determines whether or not the check group ID of the concurrent disease name etc. in the adaptive disease name master database [m] is greater than zero. If greater than 0 (YES), the process proceeds to step S09, and if not greater than 0 (NO), the process proceeds to step S11.

  In step S <b> 09, the control unit 130 checks whether the name of the disease to be checked such as the name of a comorbidity with respect to the name of the disease [i] is registered as a name of the other disease. The details of the process for checking the receipt description such as the names of comorbidities will be described later.

  In step S <b> 10, the control unit 130 determines whether the receipt description check result such as the name of a coexisting disease is a check OK. If it is OK to check the names of comorbidities (YES), the process proceeds to step S11. If it is not OK to check the names of comorbidities (NO), the process proceeds to step S12.

  In step S <b> 11, the control unit 130 presents “there is an applicable disease name” as the receipt check result, and ends the receipt check process.

  In step S12, the control unit 130 stores the receipt description check error information such as the name of a coexisting disease in a work variable, and returns to step S06.

  In step S <b> 13, the control unit 130 determines whether or not the receipt description check error information such as a coexisting disease name is stored in the work variable. If stored (YES), the process proceeds to step S14. If not stored (NO), the process proceeds to step S15.

  In step S <b> 14, the control unit 130 presents “receipt check error such as comorbidity name” as a receipt check result, displays an error, and ends the receipt check process.

  In step S <b> 15, the control unit 130 presents “no applicable disease name” as the receipt check result, displays an error, and ends the receipt check process.

  Next, the receipt description check processing procedure for the names of comorbid diseases in step S09 in FIG. 12 will be described with reference to FIG. In step S <b> 21, the control unit 130 acquires the check master database information for comorbidity name etc. using the attached document ID and the check group ID for the comorbidity name etc. of the adaptive disease name master database [m] as a link key.

  In step S22, the control unit 130 sets a work single comparison result flag to 0. The single workpiece comparison result flag includes -1 (with error), 0 (unchecked), and 1 (no error).

  In step S <b> 23, the control unit 130 starts loop acquisition for each code from the head to the EOD for the comorbid disease name check target disease name code in the comorbid disease name check master database 148. If acquisition to EOD has not been completed (NO), the process proceeds to step S24, and if processing has been completed to EOD (YES), the process proceeds to step S35.

  In step S24, the control unit 130 determines whether or not the serial number in the group of the check master database [x] such as a coexisting disease name is different from the serial number of [x-1] processed immediately before. If not different (NO), the process proceeds to step S25, and if different (YES), the process proceeds to step S26.

  In step S25, the control unit 130 determines whether or not the single workpiece comparison result flag is -1 (there is an error). When it is −1 (YES), the process proceeds to step S23, and when it is not −1 (NO), the process proceeds to step S28.

  In step S26, the control unit 130 determines whether or not the single workpiece comparison result flag is 1 (no error). If it is 1 (YES), the process proceeds to step S35. If it is not 1 (NO), the process proceeds to step S27.

  In step S <b> 27, the control unit 130 sets a single workpiece comparison result flag to 0.

  In step S <b> 28, the control unit 130 determines whether or not the disease name sequence number in the check master database [x] such as a coexisting disease name is 0. If the disease name sequence number is 0 (YES), the process proceeds to step S29. If the disease name sequence number is not 0 (NO), the process proceeds to step S30.

  In step S29, the control unit 130 sets only the complication name check target disease name codes in the complication disease name check master database [x] as comparison targets. On the other hand, in step S30, the control unit 130 sets the range of the disease name code array [x + y] to be checked for comorbidity name etc. up to the same serial number as the disease name serial number of the comorbidity name check master database [x] as a comparison target.

  In step S31, the control unit 130 determines whether or not the check target disease name code such as the comorbid disease name to be compared set in step S29 or step S30 is registered in the receipt disease name (the check target disease name code such as the coexisting disease name and the receipt disease name). Comparison processing). The details of the comparison process between the disease name code to be checked such as the name of a comorbidity disease and the name of a receptor disease will be described later.

  In step S <b> 32, the control unit 130 determines whether or not the comparison result between the check target disease name code such as the coexisting disease name and the receipt disease name has no error. If there is no error (YES), the process proceeds to step S33, and if there is an error (NO), the process proceeds to step S34.

  In step S33, the control unit 130 sets the single workpiece comparison result flag to 1 (no error), and returns to step S23. On the other hand, in step S34, the control unit 130 sets the workpiece single unit comparison result flag to -1 (with an error), and returns to step S23.

  In step S <b> 35, the control unit 130 determines whether there is a registration of a disease name to be checked such as a coexisting disease name, that is, whether the current work unit comparison result flag is 1 (no error). If there is a registration of a check target disease name such as a coexisting disease name (YES), the process proceeds to step S36, and if there is no registration of a check target disease name such as a coexisting disease name (NO), the process proceeds to step S37.

  In step S <b> 36, the control unit 130 sets “check OK” as a check result of the receipt description check for the names of comorbidities. In step S <b> 37, the control unit 130 sets a check result of the receipt description such as a comorbidity name to “check NG”.

  Next, a comparison processing procedure of the disease name code to be checked such as the name of a coexisting disease in step S31 in FIG. 13 and the name of the received disease will be described with reference to FIG. In step S <b> 41, the control unit 130 determines whether or not the single code “disease name serial number” in the check master database [x] for checking the concurrent disease name etc. is zero. If the single code “disease name serial number” is 0 (YES), the process proceeds to step S42. If the single code “disease name serial number” is not 0 (NO), the process proceeds to step S43.

  In step S42, the control unit 130 checks whether a modifier of the comorbid disease name check master database [x] is added to the current disease name code [i], which is the current comparison target, and checks the comorbid disease name etc. The comparison process between the disease name code and the received disease name is terminated. Details of step S42 will be described later.

  In step S43, the control unit 130 checks whether or not the comorbid disease name check target databases in the comorbid disease name check master database [x] to [x + y] are registered in the same receipt disease name, and checks the comorbid disease name and other check target disease name codes. And the process of comparing the name of the received disease are terminated. Details of step S43 will be described later.

  Next, FIG. 14 shows a processing procedure for checking whether or not the modifier of the complication disease name check master database [x] is added to the current disease name code [i] to be compared in step S42 of FIG. 15 will be described. In step S51, the control unit 130 determines the prescription No. of the receptor disease name [i] to be compared. A prescription database record is acquired using as a link key. The prescription database includes serial numbers, prescription numbers. This is a database composed of items of code names (and code names).

  In step S52, the control unit 130 starts loop acquisition from the top to EOD for the prescription database [j]. If the acquisition has not been completed up to EOD (NO), the process proceeds to step S56, and if the process has been completed up to EOD (YES), the process proceeds to step S53.

  In step S <b> 53, the control unit 130 determines whether or not the check process F of the check master database [x] such as a coexisting disease name is 1 (except for). When the check process F is 1 (YES), the process proceeds to step S54, and when the check process F is not 1 (NO), the process proceeds to step S55.

  In step S54, the control unit 130 sets the check result to “no error” and ends the process in step S42. On the other hand, in step S55, the control unit 130 sets the check result to “error” and ends the process of step S42.

  In step S56, it is determined whether or not the single code of the prescription database [j] is a modifier code. If it is a modifier code (YES), the process proceeds to step S57, and if it is not a modifier code (NO), the process returns to step S52.

  In step S57, the control unit 130 determines whether or not the single code of the prescription database [j] matches the code for the receipt computer processing system of the check master database [x] such as a coexisting disease name. If they match (YES), the process proceeds to step S58. If they do not match (NO), the process returns to step S52.

  In step S <b> 58, the control unit 130 determines whether or not the check process F of the check master database [x] such as a coexisting disease name is 1 (except for). When the check process F is 1 (YES), the process proceeds to step S59, and when the check process F is not 1 (NO), the process proceeds to step S60.

  In step S59, the control unit 130 sets the check result to “error present”, and ends the process of step S42. On the other hand, in step S60, the control unit 130 sets the check result to “no error” and ends the process in step S42.

  Next, FIG. 16 shows the procedure of the check process in step S43 of FIG. 14 for checking whether or not the complication name check target database names [x] to [x + y] of the complication disease name check target database are registered in the same receipt disease name. It explains using. In step S <b> 71, the control unit 130 starts a loop process from the top to the EOD for the receptor disease name. If the process has not been completed up to EOD (NO), the process proceeds to step S72. If the process has been completed to EOD (YES), the process proceeds to step S76.

  In step S <b> 72, the control unit 130 determines whether or not the single code of the receptor disease name [i ′] matches the code for the receipt computer processing system in the check master database [x] of the concurrent disease name and the like. If they match (YES), the process proceeds to step S73. If they do not match (NO), the process returns to step S71.

  In step S <b> 73, the control unit 130 determines whether or not there are a plurality of pieces of single code information in the check master database 148 of the concurrent disease name or the like to be compared this time. When there are a plurality of codes (YES), the process proceeds to step S74, and when there are not a plurality of codes (NO), the process proceeds to step S77.

  In step S <b> 74, the control unit 130 checks whether the single codes of the remaining comorbid disease name check master database 148 are registered in the same receptor disease name. Details of step S74 will be described later.

  In step S75, the control unit 130 determines whether or not the check result in step S74 is error free (all match). When there is no error (YES), the process proceeds to step S77, and when there is no error (NO), the process returns to step S71.

  In step S76, the control unit 130 sets the check result to “error present” and ends the process of step S43. On the other hand, in step S77, the control unit 130 sets the check result to “no error” and ends the process of step S43.

  Next, the procedure of the check process in step S74 in FIG. 16 for checking whether the single codes of the remaining comorbid disease name check master database 148 are registered in the same receptor disease name will be described with reference to FIG. In step S <b> 81, the control unit 130 determines the prescription No. of the receptor disease name [i ′] to be compared. A prescription database record is acquired using as a link key.

  In step S82, the control unit 130 starts loop acquisition from [x + 1] to [x + y] for the single code information in the coexisting disease name check master database 148. If the acquisition has not been completed up to EOD (NO), the process proceeds to step S84. If the process has been completed to EOD (YES), the process proceeds to step S83.

  In step S83, the control unit 130 sets the check result to “no error” and ends the process of step S74.

  In step S84, the control unit 130 starts loop acquisition from the top to EOD for the prescription database [j]. If acquisition to EOD has not been completed (NO), the process proceeds to step S86, and if processing has been completed to EOD (YES), the process proceeds to step S85.

  In step S85, the control unit 130 sets the check result to “error present” and ends the process in step S74.

  In step S86, it is determined whether or not the single code in the prescription database [j] matches the code for the receipt computer processing system in the check master database [x ′] such as a comorbid disease name. If they match (YES), the process proceeds to step S87. If they do not match (NO), the process returns to step S84.

  In step S87, the control unit 130 continues the comparison of the unit code information in the next comorbid disease name check master database 148, and returns to step S82.

  Although the embodiment of the present invention has been described above, the prescription check device 100 may further execute the following processing.

  For example, the control unit 130 of the prescription check apparatus 100 includes the disease name A ′ and the disease name B ′ or the modifier C ′ of the disease name A ′ and the disease name A in the applicable disease name of the medicine to be checked, and the disease name A ′. Is matched with the indication A of the above-mentioned medicine registered in the check master database 148 of the comorbidity name, etc. 1st mark display according to the 1st case which did not correspond and the 2nd case where modifier C 'did not correspond with modifier C of the above-mentioned medicine registered in check master database 148 such as a comorbid disease name It is good also as switching the presence or absence of. Specifically, the first mark may be displayed in any of the first case and the second case, and the first mark may not be displayed in other cases. As a result, the type of error display can be easily recognized.

  In addition, the control unit 130 of the prescription check apparatus 100 includes the disease name A ′ and the disease name B ′ or the modifier C ′ of the disease name A ′ and the disease name A in the applicable disease name of the drug to be checked, It is determined that the disease name B ′ or the modifier C ′ should be excluded from the applicable disease name of the medicinal product, and the disease name B ′ or the modifier C ′ is registered in the check master database 148 for comorbid disease names etc. It is determined that the disease name B ′ or the modifier C ′ should not be excluded from the third case that matches the indication B or the modifier C of the medicine, and the indication of the medicine to be checked, and Depending on the fourth case where the disease name B ′ or the modifier C ′ does not match the disease name B or the modifier C registered in the check master database 148 of the concurrent disease name etc., the second Mark display It is also possible to switch the no. Specifically, the second mark may be displayed in either of the first case and the second case, and the second mark may not be displayed in other cases. As a result, the type of error display can be easily recognized.

  Furthermore, in the above-described embodiment, the disease name A ′ and the disease name B ′ or the modifier C ′ of the disease name A ′ and the disease name A are included in the indication name of the medicine to be checked, and the disease name A ′ is the name of the comorbidity. The matching disease name A of the above medicinal product registered in the equivalency check master database 148, the disease name B ′, or the modifier C ′ is the indication of the disease name B registered in the complication disease name check master database 148, or When it does not coincide with the modifier C, an error display indicating that the disease name B or the modifier C is not included in the indication name of the medicine to be checked is executed.

  In addition to this, when the disease name B ′ of the drug to be checked matches the indication disease name B of the drug registered in the check master database 148 of the coexisting disease name, the disease name A ′ or the modifier C ′ coexists. It is detected whether or not it matches the indication name A or the modifier C of the above-mentioned pharmaceutical registered in the disease name check master database 148, and if it does not match, the indication disease name A or the modifier C is Further, it may be determined whether or not to execute an error display indicating that it is not included in the indication name of the medicine to be checked. This determination is easily performed by setting a flag indicating which of the applicable disease names A and B has priority in advance.

  That is, when the disease name A ′ matches the indication disease name A, but the disease name B ′ or the modifier C ′ does not match the indication disease name B or the modifier C, the disease name B or modification An error display is executed to indicate that the word C is not included in the name of the indication for the drug to be checked, and the disease name B ′ matches the indication disease name B, but the disease name A ′ or the modifier C ′ When the disease name A or the modifier C does not match, the error display indicating that the disease name A or the modifier C is not included in the indication name of the medicine to be checked may not be executed. In addition, it is possible to easily realize exception handling in which the applicable disease name B is prioritized. In addition, when giving priority to the disease name A, the disease name A and the disease name B may be interchanged in the above processing.

  Furthermore, the complication disease name check master database 148 further stores a third indication disease name C in addition to the indication disease name A and the indication disease name B for the drug, and the control unit 130 stores other information in addition to the indication disease name A. In the case where further check of the applicable disease names B and C is necessary, other indication disease names B ′ and C ′ other than the disease name A ′ matching the indication disease name A included in the indication of the indication disease of the drug to be checked are the indication disease name B, Whether or not it matches with the disease name C is detected, and if it does not match at least one of the disease name B and the disease name C, the disease name B or the disease name C that did not match is checked. It is good also as executing the display which shows that it is not included in the indication name of a target pharmaceutical. As a result, even when three indications A ′, B ′, and C ′ are included in the indications of the target medicine for the check, the indications B ′ and C ′ are at least the indications B and C. You can easily check that one does not match. By performing detection and display in the same manner, it is possible to check four or more indications of indications. In the above description, it is assumed that three indications A, B, and C are checked. For example, in addition to the indication A, the modifiers C and D are checked, or This method can be applied not only to the disease name but also to the case where modifiers are mixed, as in the case of checking the disease name B and the modifier C in addition to the adaptive disease name A.

  In addition, in the above case, the control unit 130 may further check other indications B and C for other indications, and other indications B ′ and C ′ included in the indications for the drug to be checked It is detected whether or not it matches with B and adaptive disease name C, and if it does not match with adaptive disease name B and adaptive disease name C, the adaptive disease name of both adaptive disease name B and adaptive disease name C is checked It is good also as displaying the message which shows that it is not contained in the applicable disease name of the object pharmaceutical. As a result, even when three indications A ′, B ′, and C ′ are included in the indication of the target disease of the medicine to be checked, the indications B ′ and C ′ are the indications B and C, respectively. You can easily check for inconsistencies.

  By performing detection and display in the same manner, it is possible to check four or more indications of indications. In the above description, it is assumed that three indications A, B, and C are checked. For example, in addition to the indication A, the modifiers C and D are checked, or In addition to the adaptive disease name A, this technique can be applied not only when the adaptive disease name B and the modifier C are checked, but also when the modifier is mixed.

  For example, the complication disease name check master database 148 further stores a modifier D in addition to the indication disease name A and the indication disease name B for the drug, and the control unit 130 further needs to check the indication disease name B, and When the modifier D is further checked, whether or not another indication disease name B ′ included in the indication name of the medicine to be checked matches the indication disease name B, and the indication of the medicine to be checked It is detected whether another modifier D ′ included in the name matches the modifier D. If any of the modifiers D ′ does not match, the indication disease name B or the modifier D that did not match is indicated. A display indicating that it is not included in the disease name is executed. Thereby, even when two indications A ′, B ′ and one modifier D ′ are included in the indication of the target disease of the medicine to be checked, the indication B ′ does not match the indication B, and , It can be easily checked that the modifier D ′ does not match the modifier D.

  As described above, the prescription check apparatus 100 according to the present embodiment has the first indication of disease name (for example, disease name A) and the second indication of disease name (for example, disease name B) for the drug, or the first indication. Included in the indication information of the target disease name master database 146 for storing the first modifier for the disease name (disease name A) (for example, modifier C such as mild) and the check master database 148 for comorbid disease names, etc. Obtaining an indication for an indication (eg, disease name A ′, disease name B ′), or an indication for an indication disease name (disease name A ′) and an indication disease name (disease name A ′) (eg, a modifier C ′ such as mild) When the adaptive disease name (disease name A ′, disease name B ′) included in the disease information includes the adaptive disease name that matches the first adaptive disease name (disease name A), the adaptive disease name that matches the first adaptive disease name (disease name A) ( Disease name A ' And whether or not it is necessary to further check other indication names (disease name B ′) included in the indication information, or the check of the modifier (modifier C ′) included in the indication information is further performed. It is determined whether it is necessary (that is, whether or not the check group ID of the comorbidity name etc. is greater than 0), and if further check is required, another indication disease name (disease name B ′) included in the indication information, or Detect whether or not the modifier (modifier C ′) included in the indication information matches the second indication name (disease name B) or the first modifier (modifier C). A control unit 130 that executes a display indicating that the second indication of disease name (disease name B) or the first modifier (modifier C) is not included in the indication information when there is no such indication. To do.

  Thereby, even if the complicated indication which has the relationship of several coexisting disease names and modifiers is matched with one pharmaceutical, a disease name can be checked reliably. Therefore, it is possible to shorten the hospital receipt check work time and improve the work efficiency. In addition, the reduction in the receipt assessment can suppress a decrease in the medical treatment fee originally obtained by the medical institution.

  Further, the control unit 130 of the prescription check device 100 according to the present embodiment, when the other indication name (disease name B ′) included in the indication information does not match the second indication name (disease name B), In response to a case where the modifier (modifier C ′) included in the indication information does not match the first modifier (modifier C), the first mark display (for example, FIG. Switch the presence / absence of the white inverted triangle mark). As a result, the type of error display can be easily recognized.

  In addition, the complication disease name check master database 148 of the prescription check apparatus 100 according to the present embodiment stores an exclusion flag (check processing F) for each indication disease name or for each modifier, and the control unit 130 stores the second It is determined whether the indication disease name (disease name B) or the first modifier (modifier C) should be excluded according to the exclusion flag (check processing F), and other indications included in the indication information If further check of the disease name (disease name B ′) is necessary, or if further check of the modifier (modifier C ′) included in the indication information is necessary, the second indication disease name (disease name B), or When it is determined that the first modifier (modifier C) is to be excluded, another indication of disease name (disease name B ′) included in the indication information or a modifier (modification included in the indication information) The word C ′) is the second indication of disease name (disease name B), or It is detected whether or not it matches with one modifier (modifier C). If there is a match, the second disease name to be excluded (disease name B) or the first modifier (modifier C) ) Is displayed to indicate that it is included in the indication information. Thereby, it can be checked reliably whether the 2nd indication disease name or the 1st modifier is excluded.

  In addition, the control unit 130 of the prescription check device 100 according to the present embodiment determines that the second indication name (disease name B) or the first modifier (modifier C) should be excluded. , When the other indication name (disease name B ′) included in the indication information matches the second indication name (disease name B), the second indication name (disease name B), or the first modifier ( When it is determined that the modifier C) should not be excluded, the other indication name (disease name B ′) included in the indication information does not match the second indication name (disease name B). In response, the presence / absence of the second mark display is switched. As a result, the type of error display can be easily recognized.

  Moreover, the control part 130 of the prescription check apparatus 100 of this Embodiment is the 2nd indication disease name, when the indication disease name (disease name B ') contained in indication information corresponds with the 2nd indication disease name (disease name B). Different from the indication disease name (disease name B ') that matches (disease name B), the indication disease name (disease name A') included in the indication information, or the modifier (modifier C ') included in the indication information , The first indication of disease name (disease name A) or the first modifier (modifier C) is detected, and if not matched, the first indication of disease name (disease name A), Alternatively, it is determined whether or not to display that the first modifier (modifier C) is not included in the indication information. As a result, it is possible to easily realize exception processing in which the second applicable disease name (disease name B) is prioritized over the first applicable disease name (disease name A). In addition, when giving priority to the 1st indication disease name (disease name A), what is necessary is just to replace disease name A and disease name B in the said process.

  In addition to the first indication of disease name (disease name A) and the second indication of disease name (disease name B) for the drug, the check master database 148 for comorbid disease names of the prescription check apparatus 100 according to the present embodiment includes the third In addition, the control unit 130 further stores other indication names included in the indication information when it is necessary to check other indication names (disease name B ′ and disease name C ′). It is detected whether (disease name B ′ and disease name C ′) matches the second indication name (disease name B) and the third indication name (disease name C), and at least the second indication name (disease name) B) and the second indication of disease name (disease name B) or the third indication of disease name (disease name C) that did not match when one of the third indication names (disease name C) does not match A display indicating that it is not included in the indication information is executed. As a result, even if three indication names (disease name A ′, disease name B ′, disease name C ′) are included in the indication name of the medicine to be checked, at least the indication disease name (disease name B ′, disease name C ′) is indicated. It can be easily checked that it does not match one of the disease name (disease name B) and the indication disease name (disease name C).

  Moreover, the control part 130 of the prescription check apparatus 100 of this Embodiment WHEREIN: When the check of other indication disease names (disease name B 'and disease name C') is further required, the other indication disease name (disease name) contained in indication information B ′ and disease name C ′) are detected whether they match the second indication name (Disease name B) and the third indication name (Disease name C), the second indication name (Disease name B), And when it does not correspond with the 3rd indication disease name (disease name C), both indication disease names of the 2nd indication disease name (disease name B) and the 3rd indication disease name (disease name C) are used as indication information. Display a message indicating that it is not included. As a result, even when three indication names (disease name A ′, disease name B ′, disease name C ′) are included in the indication disease name of the medicine to be checked, the indication disease name (disease name B ′, disease name C ′) is the indication disease name. (Disease name B) and indication disease name (Disease name C) can be easily checked to be inconsistent with each other.

  In addition to the first indication of disease name (disease name A) and the second indication of disease name (disease name B) for the medicine, the check master database 148 of the comorbidity name etc. of the prescription check device 100 of the present embodiment includes the second The modifier 130 (for example, the modifier D) is further stored, and the control unit 130 further needs to check another indication of disease name (disease name B ′) included in the indication information, and is included in the indication information. If other modifiers (eg, modifier D ′) need to be further checked, is the other indication name (disease name B ′) included in the indication information matched with the second indication name (disease name B)? And whether or not another modifier (modifier D ′) included in the indication information matches the second modifier (modifier D), and any of them did not match The second indication of disease (disease name B) that did not match, or Modifiers (modifier D) is to execute a display indicating that it is not included in the indications information. As a result, even if two indication names (disease name A 'and disease name B') and one modifier (modifier D ') are included in the indication name of the medicine to be checked, the indication disease name (disease name) It can be easily checked that B ′) does not match the name of the disease (disease name B) and that the modifier (modifier D ′) does not match the modifier (modifier D).

  As mentioned above, although embodiment concerning this invention has been explained in full detail with reference to drawings, the function of each apparatus mentioned above may be realized by a computer program.

  A computer that realizes the functions of the above-described device by a program includes an input device such as a keyboard, a mouse, and a touch pad, an output device such as a display and a speaker, a CPU (Central Processing Unit), a ROM (Read Only Memory), and a RAM (Random Access). Memory, a storage device such as a hard disk device or SSD (Solid State Drive), a reading device that reads information from a recording medium such as a DVD-ROM (Digital Versatile Disk Read Only Memory) or a USB (Universal Serial Bus) memory, via a network A network card for communication is provided, and each unit is connected by a bus.

  Then, the reading device reads the program from the recording medium on which the program for realizing the function of each device is recorded, and stores the program in the storage device. Or a network card communicates with the server apparatus connected to the network, and memorize | stores the program for implement | achieving the function of said each apparatus downloaded from the server apparatus in a memory | storage device.

  Then, the CPU copies the program stored in the storage device to the RAM, and sequentially reads out the instructions included in the program from the RAM and executes them, thereby realizing the functions of the device.

  The present invention is useful for surely checking for leakage of a disease name, even if a single medicine is associated with a complex indication having a plurality of disease names and modifiers.

DESCRIPTION OF SYMBOLS 110 Input IF part 120 Display part 130 Control part 140 Database 142 Creation database 144 Pharmaceuticals master database 146 Indication disease name master database 148 Check disease master database etc.

Claims (9)

A master database storing, for each drug, a first indication name and a second indication name for the drug, or a first modifier for the first indication name;
If the indication of the indication included in the indication information of the drug to be checked, or a modifier for the indication of the indication and the indication of the indication, the indication of the indication included in the indication of the indication matches the name of the first indication, It is different from an indication name that matches the first indication name and whether or not it is necessary to check another indication name included in the indication information or a modifier check included in the indication information. Judgment, if further checking of other indications included in the indication information or modifiers included in the indication information, further indications of other indications included in the indication information, or Detecting whether the modifier included in the indication information matches the second indication name or the first modifier, and if it does not match, the second indication name, Or the first A control unit for decorative word to execute a display indicating that it is not included in the indications information,
A prescription check device comprising: The control unit matches the case where another indication disease name included in the indication information does not match the second indication disease name, and the modifier included in the indication information matches the first modifier. Switch the presence or absence of the first mark display according to the absence
The prescription check device according to claim 1. The master database stores an exclusion flag for each indication name or for each modifier,
The control unit determines whether the second indication disease name or the first modifier is to be excluded according to the exclusion flag, and includes other indication disease names included in the indication information. When further check is required or when it is further necessary to check a modifier included in the indication information, it is determined that the second indication name or the first modifier should be excluded. If the other indications included in the indication information or the modifier included in the indication information matches the second indication or the first modifier If it is detected and matched, the display indicating that the second indication name to be excluded or the first modifier is included in the indication information is executed.
The prescription check device according to claim 1 or claim 2. When the control unit determines that the second indication name or the first modifier is to be excluded, the other indication name included in the indication information is the second indication name. And when it is determined that the second indication or the first modifier should not be excluded, the other indications included in the indication information are the second indication Switch the presence or absence of the second mark display according to the case where it does not match the name of the indication,
The prescription check device according to claim 3.   The control unit, when an indication name included in the indication information matches the second indication name, is different from an indication name matching the second indication name and is included in the indication information It is detected whether or not a disease name or a modifier included in the indication information matches the first indication disease name or the first modifier. 5. The indication according to claim 1, wherein it is determined whether or not a display indicating that the indication name of the disease or the first modifier is not included in the indication information is executed. Prescription check device. The master database further stores a third indication name in addition to the first indication name and the second indication name for the drug,
When the control unit further needs to check the other indications, whether the other indications included in the indication information match the second indication and the third indication And if it does not match at least one of the name of the second indication and the name of the third indication, the name of the second indication that does not match or the third indication Causing a display indicating that a disease name is not included in the indication information,
The prescription check device according to any one of claims 1 to 5. When the control unit further needs to check the other indications, whether the other indications included in the indication information match the second indication and the third indication In the case where the name of the second indication is not matched with the name of the third indication, the indications of both the indication of the second indication and the indication of the third indication are Displaying a message indicating that it is not included in the indication information;
The prescription check device according to claim 6. The master database further stores a second modifier in addition to the first indication name and the second indication name for the drug,
The control unit includes in the indication information when it is necessary to further check other indications included in the indication information and further check other modifiers included in the indication information. Detecting whether or not another indication disease name matched with the second indication disease name and whether or not another modifier included in the indication information matches the second modifier If any of the indications does not match, the indication indicating that the second indication name that did not match or the second modifier is not included in the indication information is executed.
The prescription check device according to any one of claims 1 to 5. A prescription check method for each medicine, which is performed using a master database that stores a first indication name and a second indication name for the medicine, or a first modifier for the first indication name,
Obtaining an indication of the indication included in the indication information of the drug to be checked, or the indication of the indication and the indication for the indication;
If the name of the adaptive disease included in the name of the adaptive disease matches the name of the first adaptive disease, a check of another name of the adaptive disease that is different from the name of the adaptive disease that matches the name of the first adaptive disease and is included in the indication of the indication; Or determining whether further checking of modifiers included in the indication information is necessary;
When it is necessary to check another indication of disease name included in the indication information or a modifier included in the indication information, another indication name of the indication included in the indication information or the indication Detecting whether a modifier included in the information matches the second indication name or the first modifier;
If not matched, executing a display indicating that the second indication name or the first modifier is not included in the indication information;
Including prescription check method.